Murphy James B
SEC-identified person · CIK 1282721 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Mustang BIO, INC. MBIO | Interim CFO | filed 2024 - 2024 |
| Decibel Therapeutics, Inc. [DBTX] | See Remarks | filed 2022 - 2022 |
| Zeta Acquisition Corp II WHWK | See Remarks | filed 2017 - 2017 |
| GI Dynamics, INC. GID | Chief Financial Officer | filed 2016 - 2016 |
| Oncotelic Therapeutics, Inc. OXGN | Chief Financial Officer | filed 2006 - 2010 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.